Press release
Asia-Pacific Anticoagulants Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026
Asia-Pacific anticoagulants market is estimated to grow at a CAGR of 7.8% during the forecast period. Researchers from the National Center for CVD in China have examined the prevalence and treatment of increased CVD risk in 1.7 million people from the China PEACE Million Persons Project. It is a Chinese government-funded project being conducted during 2014–2015 across four provinces in the country for CVD screening and management. Of approximately 1.7 million participants with the age group of 35-75 years, 9.5% had an increased risk for CVD. This results in an increasing CVD incidence in the region, which is driving the adoption of anticoagulants in the country.Get Free Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-anticoagulants-market
A vitamin K antagonist is utilized for the treatment of thromboembolism with cardiac valve replacement, thromboembolic events post-myocardial infarction, venous thromboembolism, pulmonary embolism, and thromboembolism with atrial fibrillation. In vitamin K antagonist (VKA) anticoagulant, warfarin is the most commonly utilized medication to reduce the risk of stroke in certain atrial fibrillation patients with risk factors. Additionally, NOACs are the ideal suggested drug class compared to warfarin, except for patients suffering from moderate to severe mitral stenosis or an artificial heart valve. NOACs comprises edoxaban, dabigatran, apixaban, and rivaroxaban.
A Full Report of Asia-Pacific Anticoagulants Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-anticoagulants-market
Scope of the Asia-Pacific Anticoagulants Market
Market Coverage
Market number available for 2019-2026
Base year- 2019
Forecast period- 2020-2026
Segment Covered- By Type and Application
Regions Covered- China, India, Japan, and Rest of Asia-Pacific
Competitive Landscape- Cipla Ltd., Bristol Myers Squibb Co., Pfizer Inc., Daiichi Sankyo Co. Ltd., and Boehringer Ingelheim GmbH
Recent Strategic Initiatives in the Asia-Pacific Anticoagulants Market
In June 2020, Gland Pharma Ltd. along with its partners Athenex Pharmaceutical Division and MAIA Pharmaceuticals Inc declared the introduction of a ready-to-use Bivalirudin injection in the US. This injection is intended for use as an anticoagulant among patients who are experiencing percutaneous coronary intervention (PCI), which includes patients suffering from heparin-induced thrombocytopenia and thrombosis syndrome, and heparin-induced thrombocytopenia.
In October 2019, Morepen Labs has added three new drugs, including UDCA (for liver ailments), Rivaroxaban (cardiac segment), and Vildagliptin (diabetes segment) to its active pharmaceutical ingredients (API) portfolio. Rivaroxaban is an anticoagulant which is a blood thinner.
Asia-Pacific Anticoagulants Market-Segmentation
By Type
Novel Oral Anticoagulants (NOACs)
Vitamin K Antagonist
Heparin and Low Molecular Weight Heparin (LMWH)
By Application
Pulmonary Embolism
Atrial Fibrillation/Myocardial Infarction (Heart Attack)
Deep Vein Thrombosis (DVT)
Others
Asia-Pacific Anticoagulants Market– Segment by Country
China
India
Japan
Rest of Asia-Pacific
Company Profiles
AstraZeneca plc
Overview
Product Portfolio
Recent Activities
Bristol Myers Squibb Co.
Cipla Ltd.
Daiichi Sankyo Company, Ltd.
Johnson & Johnson Services, Inc.
Lupin Ltd.
Novartis International AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Reasons to Buying From us –
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-anticoagulants-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Anticoagulants Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026 here
News-ID: 2237653 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Anticoagulants
Anticoagulants Market Future Prediction Report By 2033
The global Anticoagulants Market is projected to reach approximately USD 86.7 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2033.
Anticoagulants Market Overview
The Anticoagulants Market is witnessing robust growth driven by the rising incidence of cardiovascular diseases, stroke, and venous thromboembolism (VTE). The increasing aging population and sedentary lifestyles are major contributors to the growing demand for anticoagulant therapies. Novel oral anticoagulants (NOACs),…
Anticoagulants Market Share & Size Statistics Report - 2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Anticoagulants Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $77.71 billion In 2028 At A…
Anticoagulants Market - Nurturing Cardiovascular Health: Choose Anticoagulants f …
Newark, New Castle, USA: The "Anticoagulants Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Anticoagulants Market: https://www.growthplusreports.com/report/anticoagulants-market/7691
This latest report researches the industry structure, sales, revenue, price and…
Anticoagulants Market Forecast: What You Need To Know?
The Latest research study released by HTF MI "Global Anticoagulants Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research are Players Profiled…
Anticoagulants Market Situation, Major Drivers and Trends
Transparency Market Research (TMR) has published a new report titled, "Anticoagulants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026". According to the report, the global anticoagulants market was valued at US$ 21,759.3 Mn in 2018 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of obesity, increase in hip and knee surgeries, and surge in cases of coagulation disorders are…
Anticoagulants Drug Market: Current Challenges And Future Prospects In Anticoagu …
Anticoagulants Drug Market report will provide one with overall market analysis, statistics, various trends, drivers, opportunities, restraints, and every minute data relating the Anticoagulants Drug market necessary for forecasting its revenue, factors propelling & growth. The Anticoagulants Drug market study provides unique guidance in thoughtful details regarding the development factors and has used a top-down and bottom-up approach to keep it error-free and accurate. Our expert analysts have used extensive…
